267 results in 0.0059 seconds.
-
S-444823
Discovery of S-444823, a potent CB1/CB2 dual agonist as an antipruritic agent (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22421019 -
SAB-378
CB1 receptors mediate the analgesic effects of cannabinoids on colorectal distension-induced visceral pain in rodents (full – 2007)http://www.jneurosci.org/content/29/5/1554.long ... -
SAD-448
Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists (abst – 2013)http://www... -
ENDOCANNABINOIDS* > 2014
Endocannabinoid Modulation of Cortical Up-States and NREM Sleep (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919802/
Antidepressants and Changes in Concentration of Endocannabinoids and Nacylethanolamines in Rat Brain Structures. (full – 2014) http://download.springer.com/static/...13e4a&ext=.pdf Quantification of an... -
RWJ-400065
Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors (full - 2007)http://www.ncbi.nlm.nih.gov/pmc/a... -
S-444823
Discovery of S-444823, a potent CB1/CB2 dual agonist as an antipruritic agent (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22421019 -
4(PM49)
Synthetic cannabinoid quinones: Preparation, in-vitro antiproliferative effects and in-vivo prostate antitumor activity (abst – 2013)http://www.sci... -
RIMONABANT / ACOMPLIA / SR141716 / SR1
Getting high on the endocannabinoid system (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997295/
Involvement of the Cannabinoid CB1 Receptor in Modulation of Dopamine Output in the Prefrontal Cortex Associated with Food Restriction in Rats (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954872/
Vascular targets for cannabinoids: animal and human studies (full – 2014) http://onlinelibrary.wiley.com/doi/1...bph.12560/full
2012 Division of Medicinal Chemistry Award Address: Trekking the Cannabinoid Road: A Personal Perspective (full– 2014)http://www.ncbi.nlm.n... -
R(+)-METHANANANDAMIDE / AM-356
(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability (abst – 1994)http://www.ncbi.nlm.nih.gov/pubmed/8021930
Cannabinoids might reduce spasticity in multiple sclerosis (full – 2000) http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Protective effects of cannabinoid receptor ligands analogous to anandamide against cocaine toxicity (abst – 2001)http://www.ncbi.nlm.nih.gov/pubmed/11828716
Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: a possible mechanism (abst – 2002) http://www.... -
PB-22 /QUPIC / 'CRAZY MONKEY'
'Crazy Monkey' Poisons Man and Dog: Human and canine seizures due to PB-22, a novel synthetic cannabinoid (full – 2014)http://informahealthcare.com... -
PF-3845
Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain (full – 2009)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692831/ Inhibition of monoacylglycerol lipase (MAGL) attenuates NSAID-induced gastric hem... -
OMDM-2
Novel selective and metabolically stable inhibitors of anandamide cellular uptake (abst – 2003) http://www.ncbi.nlm.nih.gov/pubmed/12732359
In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake (abst – 2004)http://w... -
ORG-27569
Parameterization of Org27569: An allosteric modulator of the cannabinoid CB(1) G protein-coupled receptor (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145811/ Allosteric modulator ORG27569 induces CB1... -
DAGL / DIACYLGLYCEROL LIPASE > 2008-2014
Presence of functional cannabinoid receptors in human endocrine pancreas. (abst – 2008) http://www.frontiersin.org/publications/18092149 Autocrine Endocannabinoid Signaling through CB1 Receptors Poten... -
CBR - GPR158 / CANNABINOID RECEPTOR > 2009-2013
The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers....
